Bee Venom Acupuncture for the Treatment of Frozen Shoulder

Summary

The purpose of this study is to evaluate the effectiveness of combined bee venom acupuncture (BVA) and physiotherapy (PT) on frozen shoulder, and whether if the effect of BVA is dose effective.

Conditions

• Frozen Shoulder

Interventions

PROCEDURE

1:10,000 bee venom (BV) acupuncture

after skin test for hypersensitivity to bee venom (0.05ml of 1:30,000 bee venom, SC at LI11) * 1st visit : SC 0.4ml of 1:10,000 BV at 4 points (0.1ml for each points) * 2nd visit : SC 0.6ml of 1:10,000 BV at 6 points (0.1ml for each points) * 3rd visit : SC 0.8ml of 1:10,000 BV at 8 points (0.1ml for each points) * 4th to 16th visit : SC 1.0ml of 1:10,000 BV at 10 points (0.1ml for each points)

PROCEDURE

1:30,000 bee venom (BV) acupuncture

after skin test for hypersensitivity to bee venom (0.05ml of 1:30,000 bee venom, SC at LI11) * 1st visit : SC 0.4ml of 1:30,000 BV at 4 points (0.1ml for each points) * 2nd visit : SC 0.6ml of 1:30,000 BV at 6 points (0.1ml for each points) * 3rd visit : SC 0.8ml of 1:30,000 BV at 8 points (0.1ml for each points) * 4th to 16th visit : SC 1.0ml of 1:30,000 BV at 10 points (0.1ml for each points)

PROCEDURE

normal saline injection

after skin test for hypersensitivity to bee venom (0.05ml of 1:30,000 bee venom, SC at LI11) * 1st visit : SC 0.4ml of normal saline at 4 points (0.1ml for each points) * 2nd visit : SC 0.6ml of normal saline at 6 points (0.1ml for each points) * 3rd visit : SC 0.8ml of normal saline at 8 points (0.1ml for each points) * 4th to 16th visit : SC 1.0ml of normal saline at 10 points (0.1ml for each points)

PROCEDURE

physiotherapy

Physiotherapy treatment will be provided at each visit after bee venom or saline injection. * transcutaneous electrical nerve stimulation (TENS) for 15 minutes * transcutaneous infrared thermotherapy (TDP) for 15 minutes * manual physical therapy for 15 minutes * simple home exercise program

Sponsors & Collaborators

• Kyung Hee University Hospital at Gangdong

  collaborator OTHER

• Kyunghee University Medical Center

  lead OTHER

Principal Investigators

• Yonghyeon Baek, OMD, Ph.D · Kyung Hee University Hospital at Gangdong

• Byung-Kwan Seo, OMD, Ph.D · Kyung Hee University Hospital at Gangdong

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

70 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2010-01-31

Primary Completion

2010-07-31

Completion

2010-07-31

Countries

• South Korea

Study Locations